scholarly journals First case report of cerebral folate deficiency caused by a novel mutation of FOLR1 gene in a Chinese patient

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Ciliu Zhang ◽  
Xiaolu Deng ◽  
Yafei Wen ◽  
Fang He ◽  
Fei Yin ◽  
...  

Abstract Background Cerebral folate deficiency (CFD) is a neurological disease, hallmarked by remarkable low concentrations of 5-methyltetrahydrofolic acid (5-MTHF) in cerebrospinal fluid (CSF). The primary causes of CFD include the presence of folate receptor (FR) autoantibodies, defects of FR encoding gene FOLR1, mitochondrial diseases and congenital abnormalities in folate metabolism. Case presentation Here we first present a Chinese male CFD patient whose seizure onset at 2 years old with convulsive status epilepticus. Magnetic Resonance Imaging (MRI) revealed the development of encephalomalacia, laminar necrosis in multiple lobes of the brain and cerebellar atrophy. Whole Exome Sequencing (WES) uncovered a homozygous missense variant of c.524G > T (p.C175F) in FOLR1 gene. Further laboratory tests demonstrated the extremely low level of 5-MTHF in the CSF from this patient, which was attributed to cerebral folate transport deficiency. Following the intravenous and oral treatment of calcium folinate, the concentrations of 5-MTHF in CSF were recovered to the normal range and seizure symptoms were relieved as well. Conclusions One novel variation of FOLR1 was firstly identified from a Chinese male patient with tonic-clonic seizures, developmental delay, and ataxia. The WES and laboratory results elucidated the etiology of the symptoms. Clinical outcomes were improved by early diagnosis and proper treatment.

2018 ◽  
Vol 124 (1) ◽  
pp. 87-93 ◽  
Author(s):  
V.Th. Ramaekers ◽  
K. Segers ◽  
J.M. Sequeira ◽  
M. Koenig ◽  
L. Van Maldergem ◽  
...  

2012 ◽  
Vol 24 (4) ◽  
pp. 507-512 ◽  
Author(s):  
Sonya U. Steele ◽  
Sue Mei Cheah ◽  
Aravindhan Veerapandiyan ◽  
William Gallentine ◽  
Edward C. Smith ◽  
...  

2007 ◽  
Vol 38 (6) ◽  
pp. 276-281 ◽  
Author(s):  
V. Ramaekers ◽  
N. Blau ◽  
J. Sequeira ◽  
M.-C. Nassogne ◽  
E. Quadros

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. P02.171-P02.171
Author(s):  
W. Langley ◽  
K. Hyland ◽  
L. Mylacraine ◽  
J. Shoffner

2020 ◽  
Vol 10 (11) ◽  
pp. 762
Author(s):  
Sarah Mafi ◽  
Cécile Laroche-Raynaud ◽  
Pauline Chazelas ◽  
Anne-Sophie Lia ◽  
Paco Derouault ◽  
...  

Cerebral folate deficiency (CFD) is a neurological disorder characterized by low levels of 5-methyltetrahydrofolate (5-MTHF) in the cerebrospinal fluid (CSF). The prevalence of this autosomal recessive disorder is estimated to be <1/1,000,000. Fifteen different pathogenic variants in the folate receptor 1 gene (FOLR1) encoding the receptor of folate α (FRα) have already been described. We present a new pathogenic variation in the FOLR1 in a childhood-stage patient. We aim to establish the core structure of the FRα protein mandatory for its activity. A three-year-old child was admitted at hospital for a first febrile convulsions episode. Recurrent seizures without fever also occurred a few months later, associated with motor and cognitive impairment. Various antiepileptic drugs failed to control seizures. Magnetic resonance imaging (MRI) showed central hypomyelination and biological analysis revealed markedly low levels of 5-MTHF in CSF. Next generation sequencing (NGS) confirmed a CFD with a FOLR1 homozygous variation (c.197 G > A, p.Cys66Tyr). This variation induces an altered folate receptor α protein and underlines the role of a disulfide bond: Cys66-Cys109, essential to transport 5-MTHF into the central nervous system. Fortunately, this severe form of CFD had remarkably responded to high doses of oral folinic acid combined with intravenous administrations.


2020 ◽  
pp. jmedgenet-2020-106987
Author(s):  
Xuanye Cao ◽  
Annika Wolf ◽  
Sung-Eun Kim ◽  
Robert M. Cabrera ◽  
Bogdan J. Wlodarczyk ◽  
...  

Background Cerebral folate deficiency (CFD) syndrome is characterised by a low concentration of 5-methyltetrahydrofolate in cerebrospinal fluid, while folate levels in plasma and red blood cells are in the low normal range. Mutations in several folate pathway genes, including FOLR1 (folate receptor alpha, FRα), DHFR (dihydrofolate reductase) and PCFT (proton coupled folate transporter) have been previously identified in patients with CFD.Methods In an effort to identify causal mutations for CFD, we performed whole exome sequencing analysis on eight CFD trios and identified eight de novo mutations in seven trios.Results Notably, we found a de novo stop gain mutation in the capicua (CIC) gene. Using 48 sporadic CFD samples as a validation cohort, we identified three additional rare variants in CIC that are putatively deleterious mutations. Functional analysis indicates that CIC binds to an octameric sequence in the promoter regions of folate transport genes: FOLR1, PCFT and reduced folate carrier (Slc19A1; RFC1). The CIC nonsense variant (p.R353X) downregulated FOLR1 expression in HeLa cells as well as in the induced pluripotent stem cell (iPSCs) derived from the original CFD proband. Folate binding assay demonstrated that the p.R353X variant decreased cellular binding of folic acid in cells.Conclusion This study indicates that CIC loss of function variants can contribute to the genetic aetiology of CFD through regulating FOLR1 expression. Our study described the first mutations in a non-folate pathway gene that can contribute to the aetiology of CFD.


2008 ◽  
Vol 50 (5) ◽  
pp. 346-352 ◽  
Author(s):  
Vincent T Ramaekers ◽  
Jeffrey M Sequeira ◽  
Nenad Blau ◽  
Edward V Quadros

Sign in / Sign up

Export Citation Format

Share Document